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Introduction
Primary tumors of the liver, both malignant and
benign, constitute 1–2% of all pediatric tumors.1 Focal
nodular hyperplasia (FNH) represents only 2% of
these.2 FNH is a well-circumscribed, lobulated tumor.
Its typical architecture on gross examination consists of
bile ducts and a central stellate scar that contains blood
vessels that supply the hyperplastic process. Micro-
scopically, the proliferating cells are almost identical
to the surrounding hepatocytes.2 Complete surgical
resection of biopsy-proven FNH is not mandatory in
asymptomatic patients.
We report a case of FNH in a 5-year-old girl who
presented with fever and abdominal pain, and under-
went surgical treatment because of uncertain diagnosis
after imaging studies and needle biopsy.
Case Report
A 5-year-old previously healthy girl was referred to
Taichung Veterans General Hospital because of elevated
liver function profile and a liver tumor that was detected
at another hospital. She had suffered from fever and
abdominal pain for 1 week and had visited a local hos-
pital first. She had no symptoms of nausea or vomiting.
Physical examination showed mild hepatomegaly. The
liver function tests at the local hospital were elevated,
including an aspartate aminotransferase level of 68IU/L
(normal, < 37 IU/L) and an alanine aminotransferase
level of 127 IU/L (normal, < 41 IU/L). Imaging stud-
ies, including abdominal ultrasound and computed
tomography (CT), had also been performed there.
She was then referred to our hospital for further man-
agement. We found the patient’s liver function tests to
be within the normal ranges (aspartate aminotrans-
ferase/alanine aminotransferase, 28/35 IU/L). Viral
serological tests for hepatitis B and C were negative.
Alpha-fetoprotein level was 1.78 ng/mL.
Abdominal ultrasonography showed a hypoechoic,
6.9 × 4.5 cm, well-defined mass in the right lobe of
the liver. A dynamic CT scan of the liver disclosed a lob-
ulated right hepatic tumor with a dilated feeding vessel
from the right hepatic artery (Figure 1). On arterial-
and portal-venous-phase imaging, the tumor continued
to show hyperenhancement relative to normal liver
parenchyma.
Needle biopsy was performed by a pediatrician,
but no definite diagnosis could be obtained after his-
tological examination. Thus, the patient underwent
exploratory surgery by means of a Kocher incision to
obtain a pathological diagnosis. A large mass, without
adherence to adjacent structures, was immediately
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evident at the entrance to the abdomen (Figure 2).
Some blood clots, due to a previous needle biopsy,
were found around the tumor. To decrease blood loss,
Pringle’s maneuver was performed once during liver
resection. A segmentectomy of S6–7 with complete
resection of the tumor was performed. The time taken
for liver resection was 18 minutes, and liver ischemic
time was 23 minutes. Blood loss was minimal.
Gross pathological examination showed that the
tumor was well-defined, yellow to tan in color, and
6.8 × 5.3 × 4.5 cm in size, with a nodular appearance.
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Figure 1. (A and B) Dynamic computed tomography of the liver
shows a lobulated right hepatic tumor (arrow) with a dilated feed-
ing vessel from the right hepatic artery during the arterial phase.
(C) Computed tomographic angiography demonstrates a spoke-
wheel pattern (arrow) that corresponded to radiated arteries.
Figure 2. A large mass with nodular appearance, without adher-
ence to adjacent structures, was immediately evident at the
entrance to the abdomen.
Figure 3. Gross pathology of the resected tumor shows a 6-cm
tumor with nodular appearance and a centrally located vessel
(arrow), compatible with the imaging features.
It weighed 85 g. A cross section of the tumor was
multinodular, without a typical central stellate scar
(Figure 3).
Microscopically, we observed a non-encapsulated
tumor, composed of nodular hepatocytes with 
“cirrhosis-like” architecture separated by fibrous septa,
and containing bile ductule proliferation and tortuous
blood vessels (Figure 4). The hepatocytes were cyto-
logically normal. A final diagnosis of FNH was made.
After surgery, the child was doing well at 24 months
of follow-up.
Discussion
Among pediatric primary liver neoplasms, 57% are
malignant and 43% are benign.2 Benign liver tumors
in children include vascular tumors, hamartomas, ade-
nomas, and FNH. FNH can be diagnosed in any age
group, from newborns to the elderly. In children, it is
usually diagnosed between 2 and 5 years of age.3
Like other benign liver tumors, small lesions can be
asymptomatic incidental findings. Larger lesions even-
tually present with mass symptoms, usually abdominal
pain. On examination, the child usually presents with
a right upper abdominal mass.4 Laboratory tests are
unremarkable, although normal levels of α-fetoprotein
are indicative of a benign lesion.5 The 5-year-old girl
in this case report had symptoms of fever and abdom-
inal pain, due to a larger lesion of 6.8 cm in diameter.
FNH of the liver is a nodular, non-encapsulated,
occasionally multifocal (15–20%) liver mass, which
most frequently occupies the left liver lobe.6 It is usu-
ally slightly hypoechoic or isoechoic, with lobulated
contours or a hypoechoic halo on ultrasound. The
typical central scar is slightly hyperechoic, but is often
difficult to visualize on ultrasound (20% of cases).7
Ungermann et al8 reported that contrast-enhanced
ultrasonography can be the final diagnostic method for
FNH > 3 cm with a typical spoke-wheel vessel struc-
ture. If this phenomenon is not present and the cen-
tral scar is not visible, a specific diagnosis of FNH
cannot be based solely on contrast-enhanced ultra-
sound findings.
The tumor can be much more evident on CT after
intravenous contrast enhancement. On precontrast CT
scans, FNH is seen as a focal hypodense or isodense
mass. A central hypodense scar is observed in only one-
third of cases.7 In most cases (89–100%), the lesion
enhances rapidly during the arterial phase of contrast-
enhanced CT because of the prominent arterial supply
to the FNH.9 Furthermore, based on evidence pro-
vided by magnetic resonance imaging (MRI) about the
characteristics of soft tissue and vascularity of the
tumor, Hussain et al10 concluded that MRI has a higher
sensitivity and specificity for FNH than either ultra-
sonography or CT. In our case, the typical central scar
was not seen by CT or ultrasound, which was com-
patible with the pathological findings.
The possible malignant potential of FNH lesions
remains the main issue. To date, there have been no
reports of histologically proven FNH presenting with
a malignant evolution; however, cases of FNH lesions
associated with hepatocellular carcinoma (HCC) do
exist.11–13 A series of patients operated on for preop-
erative diagnosis of benign liver tumor showed 3 with
HCC diagnosed at the time of surgery.12 Petsas et al13
reported a case of HCC arising within large FNH.
This case underwent preoperative CT-guided core
needle biopsy that revealed FNH. However, the final
pathological diagnosis disclosed FNH and HCC. These
data suggest that, despite distinctive findings on radio-
graphic imaging, liver biopsy or resection might be
necessary to establish the diagnosis definitively.
Makhlouf et al14 reported that when there is doubt
about the diagnosis by imaging, needle biopsy can be
performed. In their experience, if an adequate speci-
men is obtained, the diagnosis of FNH can usually be
established on hematoxylin and eosin sections, but
only 24% of the cases in the presented series were cor-
rectly diagnosed with certainty. In our case, needle
biopsy was arranged by a pediatrician for pathological
diagnosis because of atypical findings on CT or ultra-
sound, but this form of diagnosis failed because of the
lack of typical histological characteristics of FNH. In
our experience, for patients with hypervascular tumor
or undetermined but resectable tumor, needle biopsy
for diagnosis is not favored because of risks of internal
bleeding or tumor dissemination.
From the retrospective analysis of Reymond et al,15
the outcome appears to be good for those with obser-
vation alone and those with resection. Hence, asymp-
tomatic FNH can be treated conservatively with
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Figure 4. (A) Well-defined, non-encapsulated tumor, composed of nodular hepatocytes with “cirrhosis-like” architecture, separated 
by fibrous septa. The left part is normal liver parenchyma. The septum is infiltrated by lymphocytes (arrow) (hematoxylin & eosin, 40´).
(B) Numerous duct-like structure proliferations (arrow) with scattered lymphocytes (hematoxylin & eosin, 100´).
regular follow-up. For pediatric FNH patients, Yang 
et al16 suggested that active surgical treatment by
hepatectomy should be performed if the patient has:
(1) clinical symptoms; (2) indefinite diagnosis or hep-
atitis B virus carriage; and (3) tumor size > 5 cm. Our
patient and another case reported by Feng et al17
shared some similarities clinically, and both fulfilled
the criteria for surgery.
In conclusion, FNH can present as an incidental
finding without typical appearance in children. Clinical
symptoms are dependent on tumor size and location.
The diagnosis of FNH mainly depends on imaging,
such as ultrasound, CT and MRI. However, it is diffi-
cult to differentiate from other frequent liver tumors in
children. Complete surgical resection of biopsy-proven
FNH is not mandatory in asymptomatic patients. For
symptomatic patients or those with indefinite diagno-
sis, surgical excision is suggested.
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